Globus Medical, Inc. (GMED)
NYSE: GMED · Real-Time Price · USD
75.48
-0.53 (-0.70%)
Jul 21, 2026, 9:55 AM EDT - Market open
Globus Medical Stock Forecast
Stock Price Forecast
According to 14 analysts polled by S&P Global, Globus Medical stock has a consensus rating of "Buy" and an average price target of $105.75. The average 1-year stock price forecast is 40.10% higher than the current stock price, while the lowest is $87 (+15.26%) and the highest is $122 (+61.63%).
Price Target: $105.75 (+40.10%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Globus Medical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 5 | 6 | 6 | 7 |
| Buy | 5 | 4 | 4 | 3 | 3 | 3 |
| Hold | 4 | 4 | 4 | 4 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 15 | 14 | 13 | 13 | 13 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Financial | Truist Financial | Buy Maintains $115 → $100 | Buy | Maintains | $115 → $100 | +32.49% | Jul 16, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $120 → $115 | Buy | Maintains | $120 → $115 | +52.36% | Jul 13, 2026 |
| BTIG | BTIG | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Jul 10, 2026 |
| BMO Capital | BMO Capital | Buy Initiates $94 | Buy | Initiates | $94 | +24.54% | Jul 8, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Hold Reiterates $95 → $80 | Hold | Reiterates | $95 → $80 | +5.99% | Jul 8, 2026 |
Financial Forecast
Revenue This Year
3.20B
from 2.94B
Increased by 8.98%
Revenue Next Year
3.41B
from 3.20B
Increased by 6.31%
EPS This Year
4.74
from 3.98
Increased by 19.19%
EPS Next Year
5.15
from 4.74
Increased by 8.57%
EPS and Forward PE are based on non-GAAP adjusted numbers.